A national research impact trial ‘Excellence in Innovation for Australia’ (EIA) was held in 2012 where twelve Australian universities submitted 162 case studies to EIA for assessment. The EIA trial was enabled through partnership between the contributing universities as well as representatives from industry, non-government organisations and government. 

Results released in November 2012 showed that research projects at The University of Queensland delivered outstanding economic, social and environmental benefits.   
 
The EIA study showed that the Gardasil vaccine, which protects against Human Papilloma Virus and cervical cancer, was one of the important developments to emerge from Australia in recent years. The Gardasil vaccine was co-developed by UQ’s Professor Ian Frazer and is now available in 121 countries, with more than 100 million does now distributed worldwide. The vaccine has the potential to save 250,000 lives annually.
 
The EIA trial has highlighted the importance of universities retaining focus on the outcomes of their research projects and explaining those benefits to the wider community.  
 
Other UQ examples of outstanding research impact as assessed by EIA: 
  • The Positive Parenting Program, developed at UQ by Professor Matt Sanders, was assessed as having outstanding beneficial impact. The “Triple P” program has benefited seven million children worldwide by reducing violence towards children, reducing behavioural problems in children, and reducing stress and depression in children and parents. The program is available in 18 languages in 23 countries.
  • Pesticide regulation has changed in Australia, USA, Canada and New Zealand as a result of Dr Caroline Gaus’ work at UQ which identified contamination of soil, sediment and biota due to impurities in dioxins. The outcomes of this research also influenced United Nations Environment Program activities.
  • The development of titanium fabrication technology through a UQ aerospace materials project led by Associate Professor Matthew Dargusch enabled an Australian company to win a $1 billion manufacturing contract for the F-35 Joint Strike Fighter jet.
  • Technology that improves the clarity of images from Magnetic Resonance Imaging machines resulted from a project led by Professor Stuart Crozier. The technology has been incorporated in two-thirds of the world’s high-field MRI systems sold since 1996 and facilitates vastly improved diagnostics. The global MRI market has a current estimated value of $US4.5 billion per year.
  • The world’s largest mining companies are managing production on critical slopes using GroundProbe Slope Stability Radar developed by Dr David Noon. This system monitors slope stability in 19 countries.   

On this site

Go to top